Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Yanhua Ding, First Hospital of Jilin University
ClinicalTrials.gov Identifier:
NCT01605513
First received: May 10, 2012
Last updated: May 23, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2012
  Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)